Alzheimer’s disease is difficult to diagnose – the clinical definition varies and the disease itself presents in many different ways. Of course, there’s always the pathological findings – neurofibrillary tangles, amyloid deposits etc. – but no one’s up for a brain biopsy.
The understanding of AD has dramatically changed over the past 5 years, which means the definition has also changed. There are now a variety of invasive and non invasive biomarkers to assist with diagnosis – and this paper comes to clarify the situation.
There are fourteen professors in the author list – this is the need to know. Read it here.